b12 and tirzepatide together 2D 1 H-15 N HSQC NMR experiments indicate changes to the structure of Tirzepatide with Glycine + B12

Surpassing medical therapy by large margins in both controlled and real-world data

Its important to note that Semaglutide is contraindicated for individuals with a history or family history of medullary thyroid cancer

Key Takeaways Pancreatitis affects roughly 0.3% of semaglutide users in clinical trials, far less common than nausea, which affects over 40%

In comparison, other participants who were given a placebo lost an average of only 0.4% of their initial body weight

Take our 5-minute assessment and a licensed physician will review your profile and recommend the right protocol based on your health data and goals

Zepbound (tirzepatide): Specifically approved for chronic weight management in adults with obesity or overweight conditions related to health issues